Barriers to Physical Activity Among Patients With Type 1 Diabetes
- Anne-Sophie Brazeau, RD12,
- Rémi Rabasa-Lhoret, MD, PHD12345,
- Irene Strychar, EDD, RD1235 and
- Hortensia Mircescu, MD1234
- 1Metabolic Dysfunction Laboratory, Department of Nutrition, University of Montreal, Montreal, Canada
- 2Research Center of the University of Montreal Hospital Center, Montreal, Canada
- 3Division of Endocrinology, Department of Medicine, Research Center of the University of Montreal Hospital Center, Montreal, Canada
- 4Faculty of Medicine, University of Montreal, Montreal, Canada
- 5Montreal Diabetes Research Center, Research Center of the University of Montreal Hospital Center, Montreal, Canada
- Corresponding author: Hortensia Mircescu, hortensia.mircescu{at}umontreal.ca
Abstract
OBJECTIVE—To determine, in an adult population with type 1 diabetes, barriers to regular physical activity using a diabetes-specific barriers measure (the Barriers to Physical Activity in Diabetes [type 1] [BAPAD1] scale) and factors associated with these barriers.
RESEARCH DESIGN AND METHODS—One hundred adults with type 1 diabetes answered a questionnaire assessing perceived barriers to physical activity and related factors. A1C was obtained from the medical chart of each individual.
RESULTS—Fear of hypoglycemia was identified as being the strongest barrier to physical activity. Greater knowledge about insulin pharmacokinetics and using appropriate approaches to minimize exercise-induced hypoglycemia were factors associated with fewer perceived barriers. Greater barriers were positively correlated with A1C levels (r = 0.203; P = 0.042) and negatively with well-being (r = −0.45; P < 0.001).
CONCLUSIONS—Fear of hypoglycemia is the strongest barrier to regular physical activity in adults with type 1 diabetes, who should therefore be informed and supported in hypoglycemia management.
Footnotes
-
Published ahead of print at http://care.diabetesjournals.org on 8 August 2008.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
-
- Accepted July 29, 2008.
- Received April 13, 2008.
- DIABETES CARE
